NCT02599194 · OUTCOME

Number of Treatment-Related Adverse Events

18F-FSPG PET/CT for Cancer Patients on Therapy · Source last updated 2019-01-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: adverse events
Interval / dispersion: Not reported
Time frame: Baseline to up to 2 years

What was measured

Safety and tolerability of 18F-FSPG and 18F-FDG were assessed as treatment-related adverse events, and reported as the number of events related to each treatment, without dispersion.

Groups in this outcome

18F-FSPG and 18F-FDG Intragroup Comparision

Participants sequentially receive radioimaging agents 18F-FSPG and 18F-FDG IV followed by PET/CT scan with 60 minutes. 18F-FSPG: Administered intravenously (IV) 18F-FDG: Administered intravenously (IV)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
18F-FSPG and 18F-FDG Intragroup Comparision	7

Reported measurements

18F-FSPG

Values in adverse events · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
18F-FSPG and 18F-FDG Intragroup Comparision	0	Not reported	Not reported	Not reported	Not reported

18F-FDG

Values in adverse events · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
18F-FSPG and 18F-FDG Intragroup Comparision	0	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
0
title
18F-FSPG
categories
measurements
group Id
OG000
value
0
title
18F-FDG

denoms

counts
group Id
OG000
value
7
units
Participants

description

Safety and tolerability of 18F-FSPG and 18F-FDG were assessed as treatment-related adverse events, and reported as the number of events related to each treatment, without dispersion.

groups

description
Participants sequentially receive radioimaging agents 18F-FSPG and 18F-FDG IV followed by PET/CT scan with 60 minutes. 18F-FSPG: Administered intravenously (IV) 18F-FDG: Administered intravenously (IV)
id
OG000
title
18F-FSPG and 18F-FDG Intragroup Comparision

param Type

NUMBER

reporting Status

POSTED

time Frame

Baseline to up to 2 years

title

Number of Treatment-Related Adverse Events

type

SECONDARY

unit Of Measure

adverse events

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice